INmune Bio, Inc. Appoints Timothy J. Schroeder to its Board of Directors
September 26, 2017 at 08:30 am EDT
INmune Bio Inc. announced the appointment of Timothy J. Schroeder to its board of directors. Schroeder's extensive background includes more than 35 years of clinical, academic and industry experience in global drug and device development programs, expertise that is well-aligned with the development of INmune Bio's therapeutic products. Schroeder is the CEO and founder of CTI Clinical Trial & Consulting Services.